Department of Surgery, Auckland City Hospital, Auckland, New Zealand.
Department of Gastroenterology, North Shore Hospital, Auckland, New Zealand.
Clin Transl Gastroenterol. 2023 Nov 1;14(11):e00626. doi: 10.14309/ctg.0000000000000626.
Chronic gastroduodenal symptoms are frequently overlapping within existing diagnostic paradigms, and current diagnostic tests are insensitive to underlying pathophysiologies. Gastric Alimetry has emerged as a new diagnostic test of gastric neuromuscular function with time-of-test symptom profiling. This study aimed to assess the impact to diagnosis and health care utilization after the introduction of Gastric Alimetry into clinical care.
Consecutive data of patients from 2 tertiary centers with chronic gastroduodenal symptoms (Rome-IV defined or motility disorder) having integrated care and Gastric Alimetry testing were evaluated. Changes in diagnoses, interventions, and management were quantified. Pretest and posttest health care utilization was reported. A preliminary management framework was established through experiential learning.
Fifty participants (45 women; median age 30 years; 18 with gastroparesis, 24 with chronic nausea and vomiting syndrome, and 6 with functional dyspepsia) underwent Gastric Alimetry testing. One-third of patients had a spectral abnormality (18% dysrhythmic/low amplitude). Of the remaining patients, 9 had symptoms correlating to gastric amplitude, while 19 had symptoms unrelated to gastric activity. Gastric Alimetry aided management decisions in 84%, including changes in invasive nutritional support in 9/50 cases (18%; predominantly de-escalation). Health care utilization was significantly lower post-Gastric Alimetry testing when compared with the average utilization cost in the year before Gastric Alimetry testing (mean ± SD $39,724 ± 63,566 vs $19,937 ± 35,895, P = 0.037).
Gastric Alimetry aided diagnosis and management of patients with chronic gastroduodenal symptoms by enabling phenotype-informed care. The high majority of results aided management decisions, which was associated with reduced health care utilization.
慢性胃十二指肠症状在现有的诊断模式中经常重叠,目前的诊断测试对潜在的病理生理机制不敏感。胃测压法作为一种新的胃神经肌肉功能诊断测试,具有测试时症状分析的特点。本研究旨在评估胃测压法引入临床后对诊断和医疗保健利用的影响。
对 2 家三级中心具有综合护理和胃测压法检测的慢性胃十二指肠症状(罗马 IV 定义或运动障碍)患者的连续数据进行评估。量化了诊断、干预和管理的变化。报告了测试前和测试后的医疗保健利用情况。通过经验学习建立了初步的管理框架。
50 名参与者(45 名女性;中位年龄 30 岁;18 名胃轻瘫,24 名慢性恶心呕吐综合征,6 名功能性消化不良)接受了胃测压法检测。三分之一的患者有频谱异常(18%节律紊乱/低幅度)。其余患者中,9 名患者的症状与胃振幅相关,而 19 名患者的症状与胃活动无关。胃测压法辅助管理决策的比例为 84%,包括 50 例中的 9 例(18%;主要是降级)改变侵入性营养支持。与胃测压法检测前一年的平均医疗保健利用成本相比(平均值 ± SD 39724 ± 63566 美元对 19937 ± 35895 美元,P = 0.037),胃测压法检测后的医疗保健利用显著降低。
胃测压法通过实现表型知情护理,辅助慢性胃十二指肠症状患者的诊断和管理。绝大多数结果辅助了管理决策,这与医疗保健利用的减少有关。